Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed attachment file name title question first answered answering member label
tabling member	label

Search

1135065

registered interest
date	26/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Bacterial Diseases
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government, further to the Written Answer by Baroness Blackwood of North Oxford on 4 June (HL15832), what assessment they have made of (1) the future costs to the NHS as a result of the spread of carbapenem-resistant Enterobacteriaceae, (2) the costs of new measures introduced in 2019 specifically to prevent the transmission of such Enterobacteriaceae, and (3) the views of infection control nurses on investment to prevent the transmission of such Enterobacteriaceae.
tabling member printed	Baroness Gardner of Parkes
uin	HL16692
answer	answer is ministerial correction date of answer 09/07/2019 answer text <p>Public Health England (PHE) has predicted future spread and the health and cost impact to the National Health Service of the Enterobacteriaceae Escherichia coli and a national outbreak of a highly-resistant organism, reflecting carbapenem-resistant Enterobacteriaceae. The models used in this assessment are published in the paper <em>A Risk Assessment of Antibiotic Pan-Drug-Resistance in the UK: Bayesian Analysis of an Expert Elicitation Study</em>. A copy of the paper is attached.</p><p>Such predictions are highly uncertain. There remain unknowns regarding transmission, efficacy of interventions and the additional hospital stay for infected patients (constituting a large part of the cost to the NHS).</p><p>PHE has worked with NHS colleagues, estimating the cost of controlling a carbapenemase-producing Enterobacteriaceae (CPE) outbreak in five London hospitals to be over £1 million. Monitoring costs alongside implementation of PHE’s upcoming update of the CPE toolkit for health and social care is an important component of enabling cost-effectiveness evaluation.</p><p>Staff interviewed about the challenges of implementing the existing CPE toolkit highlighted maintaining awareness and training as key challenges, alongside infection prevention resourcing. An analysis of the responses was published in the paper <em>An evaluation of a toolkit for the early detection, management, and control of carbapenemase-producing Enterobacteriaceae: a survey of acute hospital trusts in England</em>. A copy is attached.</p> answering member printed Baroness Blackwood of North Oxford attachment 1 file name A Risk Assessment of Antibiotic Pan-Drug-Resistance in the UK.pdf title Risk Assessment of Antibiotic Pan Drug Resistance 2 file name An evaluation of a toolkit for the early detection management and control of carbapenemase-producing Enterobacteriaceae. A survey of acute hospital .pdf title An evaluation of a toolkit question first answered 09/07/2019 13:34:21 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	3596 label Biography information for Baroness Gardner of Parkes

1135071

registered interest
date	26/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Migrant Workers
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what recent assessment they have made of the impact on the ability of the NHS to recruit experienced staff from the EU of the UK leaving the EU without a deal; and what plans they have to make up any shortfall in numbers of staff.
tabling member printed	Lord Jones of Cheltenham
uin	HL16698
answer	answer is ministerial correction date of answer 09/07/2019 answer text <p>The Government recognises the need for the National Health Service to be able to recruit effectively from abroad and the Immigration White Paper, <em>The UK’s future skills-based immigration system</em>, published in December 2018, sets out the foundation for a single immigration system, where it is workers’ skills that matter, not where they come from.</p><p>The Government has taken steps to ensure that European Union citizens can continue to come and work in the NHS once we have left the EU. In March 2019, we put in place legislation that ensures the continued recognition of qualifications from EU countries by all professional regulators covering the health and social care sectors. This means that EU citizens will continue to be able to come and practice in the United Kingdom once we have left the EU, even if we leave without a ‘deal’.</p><p>The NHS Long Term Plan and interim People Plan have both set out a vital strategic framework to ensure that over the next 10 years the NHS will have the staff it needs so that nurses and doctors have the time they need to care, working in a supportive culture that allows them to provide the expert compassionate care they are committed to providing. The interim People Plan sets out how part of this will be made up from an expansion of international recruitment of NHS staff.</p><p> </p> answering member printed Baroness Blackwood of North Oxford question first answered 09/07/2019 12:38:48 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	248 label Biography information for Lord Jones of Cheltenham

1135097

registered interest
date	26/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: EU Law
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what steps they have taken to assess the impact on the NHS of leaving the European regulatory framework in the event of a no-deal Brexit.
tabling member printed	Lord Taylor of Warwick
uin	HL16724
answer	answer is ministerial correction date of answer 10/07/2019 answer text <p>The Government maintains that leaving the European Union with a deal is the best outcome. However, as a responsible Government, we continue to plan and prepare for all eventualities, including a potential ‘no deal’ exit.</p><p>The Government is committed to the safe and effective regulation of medicines and medical devices in the United Kingdom. We will continue to strengthen safety while ensuring National Health Service patients and the public have fast access to new, innovative medicines.</p><p>The Government is providing short-term regulatory flexibility, in order to ensure that the UK can still import medicines from the European Economic Area (EEA), when the UK leaves the EU. We have announced that, in the event of a ‘no deal’ scenario, the UK will recognise batch testing that takes place in the EU and EEA, thus ensuring regulatory continuity so that the NHS can maintain ease of access to medicines developed and manufactured in the EU.</p><p>In the event of a ‘no deal’ exit, the Government will continue to ensure that UK patients are able to access the best and most innovative treatments and that their safety is protected.</p> answering member printed Baroness Blackwood of North Oxford question first answered 10/07/2019 15:07:17 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	1796 label Biography information for Lord Taylor of Warwick